As China forges ahead in the global race to develop a vaccine to curb the COVID-19 pandemic and as cases within China dwindle, CNBG needs research participants.
CNBG will partner with Argentina's ELEA in the vaccine trial, the Chinese company said in a statement late Friday.
The two sides discussed topics such as accelerating free-trade agreement negotiations, expanding cultural exchanges as well as the election of the World Trade Organization (WTO) Director General.